HEMACAPE ApS: Financial statements 2023
CVR: 35817115
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HEMACAPE ApS (CVR 35817115) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK -3,688 the year before. Equity in the 2023 report amounted to DKK 78,724. The solvency ratio was 29.9%.
- Gross Profit
- DKK -3,750
- Profit/Loss
- DKK -3,750
- Equity
- DKK 78,724
- Total Assets
- DKK 262,917
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -4 t. | -4 t. | 79 t. | - |
| 2022 | - | -4 t. | -4 t. | 82 t. | 0 |
| 2021 | - | -3 t. | -4 t. | 86 t. | 0 |
| 2020 | - | -3 t. | -3 t. | 90 t. | 0 |
| 2019 | - | -3 t. | -3 t. | 93 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HEMACAPE ApS has published its annual report for 2022. Gross profit came to DKK -3,688, and the net result was DKK -3,688.
About HEMACAPE ApS
HEMACAPE ApS is a Danish company of the type Anpartsselskab based in Randers NØ, founded in 2014. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of John Holflod Jeppesen. The company is owned by John Holflod Jeppesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,843 and a net result of DKK 537,377 compared with DKK -3,750 the year before. Equity in the 2025 report amounted to DKK 612,350.